Nuchal translucency measurement in the era of prenatal screening for aneuploidy using cell free (cf)DNA

Prenat Diagn. 2017 Mar;37(3):303-305. doi: 10.1002/pd.5010. Epub 2017 Feb 17.

Authors

Barbara M O'Brien¹, Jacquelyn Halliday¹, Geralyn Lambert-Messerlian^{1

2}, Elizabeth E Eklund², Edward Kloza², Glenn E Palomaki²

Affiliations

¹ Department of Obstetrics and Gynecology and Laboratory Medicine, Women and Infants Hospital and the Alpert Medical School at Brown University, Providence, RI, USA.
² Department of Pathology and Laboratory Medicine, Women and Infants Hospital and the Alpert Medical School at Brown University, Providence, RI, USA.

PMID: 28124379
DOI: 10.1002/pd.5010

No abstract available

Publication types

Letter

MeSH terms

Adult
Aneuploidy*
Cell-Free Nucleic Acids / blood*
Choice Behavior
Female
Genetic Testing / methods
Health Knowledge, Attitudes, Practice
Hong Kong
Humans
Informed Consent
Nuchal Translucency Measurement / statistics & numerical data*
Pregnancy
Prenatal Diagnosis / methods*
Surveys and Questionnaires

Substances

Cell-Free Nucleic Acids